-
Symbol
-
NEUP on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value per share
-
Latest Disclosed Shares Owned
-
875,328 shares
-
Security Ownership %
-
16%
Shares, Excluding Options vs Price
Lynx1 Capital Management LP ownership in Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP)
29 Dec 2025 - Lynx1 Capital Management LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 875,328 shares of Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP).
This represents 16% ownership of the company.
In their previous filing dated 02 Dec 2025, Lynx1 Capital Management LP had reported owning 875,328 shares, indicating a new holding.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.